Home
Shield Therapeutics

Shield Therapeutics Market Share Analysis for August 2026

Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make the difference in their everyday lives.

Industry: N/A

Domainshieldtherapeutics.com

Year Founded2008

Employees51 - 200

Annual Revenue$10M - $15M

Shield Therapeutics

Shield Therapeutics (including company regionals)

shieldtherapeutics.com

See more website traffic and engagement information

Shield Therapeutics Revenue up to August 2026 is 10M - 15M

revenue generated by Shield Therapeutics top domains

Shield Therapeutics top domains revenue over 3 years

Revenue for Shield Therapeutics top domains

shieldtherapeutics.com10M - 15M

See more with Sales Intelligence

Total visits to Shield Therapeutics's top domains

Understand Shield Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

shieldtherapeutics.com360

See more with Sales Intelligence

Avg. visit duration in Shield Therapeutics's top domains

Analyze Shield Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Shield Therapeutics's top domains

See how Shield Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

shieldtherapeutics.com1.01

See more with Sales Intelligence

Shield Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Shield Therapeutics

These are the website technologies, by industry, used by Shield Therapeutics top domains

Audio Video Media (5)

YouTube

Advertising (3)

Google Adsense

Conversion & Analytics (3)

Google Analytics

Content Management System (2)

WordPress

More Technologies

8

See all

News & Signals from Shield Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsShield Therapeutics plc had revenue of $30.4M on Jun 30th '26.Shield Therapeutics (LON: STX) reported group revenues of $30.4m for the six months ended 30 June 2026, a rise of 42% year-on-year according to the company's interim results filed on Investegate (the original snippet stated 41%).

NewsShield Therapeutics plc will hire Michael Jensen as chief financial officer on Sep 1st '26.Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Appoints Michael Jensen as chief financial officer.

NewsShield Therapeutics has revenue of $18M.(Sharecast News) - Shield Therapeutics reported first-quarter net revenue of $18m and positive EBIT on Friday, helped by a China milestone payment and continued growth in US sales of its iron deficiency treatment ACCRUFeR.